Atlas Trials

Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major

Clinical trial NCT01752153 · COMPLETED

Trial details

NCT number
NCT01752153
Sponsor
Shiraz University of Medical Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Immune Abnormalities
Start date
2012-06-01
Primary completion
2012-09-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.